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ABSTRACT
DELTAMETHRIN, A PYRETHROID INSECTICIDE, POTENTIATES LIPID
ACCUMULATION IN 3T3-L1 ADIPOCYTES
MAY 2016
TSUNG-HSIU HSIEH, B.S.A., TUNGHAI UNIVERSITY, TAIWAN
M.S., UNIVERSITY OF QUEENSLAND, AUSTRALIA
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Yeonhwa Park

Obesity is a growing concern in the world today. As we ponder about the many
causes of this global epidemic, we are driven to look at our food and the environmental
toxicants that may contribute to obesity. Deltamethrin, being a common synthetic
pyrethroid used in agriculture for pest control, is the primary insecticide this study
explores to connect with obesity in 3T3-L1 adipocytes. To investigate the relationship
between deltamethrin and adipogenesis, various concentrations were tested, 1nM, 10nM,
100nM, 1μM, and 10μM. The result indicated that higher concentration of deltamethrin
had a direct impact on fat accumulation. These experiment results indicate that
deltamethrin may potentiate adipogenesis in this model. Further in vivo studies will be
needed to validate these findings and confirm the effects of deltamethrin on obesity.

v

TABLE OF CONTENTS
Page
ACKNOWLEDGMENTS .............................................................................................................. iv
ABSTRACT..................................................................................................................................... v
CHAPTER
1. INTRODUCTION ....................................................................................................................... 1
2. LITERATURE REVIEW ............................................................................................................ 3
2.1 Obesity ......................................................................................................................... 3
2.2 Development of synthetic pyrethroids ......................................................................... 4
2.3 Deltamethrin ................................................................................................................. 7
2.4 3T3-L1 Adipocytes....................................................................................................... 8
3. MATERIALS and METHODS.................................................................................................. 10
3.1 Materials ..................................................................................................................... 10
3.1.1 Differentiation of 3T3-L1 cells, and quantification of triglyceride
and protein ..................................................................................................... 10
3.1.2 Adipocyte accumulation in 3T3-L1 cells after insecticide
treatment ........................................................................................................ 10
3.1.3 Immunoblotting analyses of 3T3-L1 cells after deltamethrin
treatment ........................................................................................................ 10
3.2 Methods ..................................................................................................................... 11
3.2.1 Differentiation of 3T3-L1 cells, and quantification of triglyceride
and protein ..................................................................................................... 11
3.2.2 Lipid accumulation in 3T3-L1 adipocytes after Deltamethrin
treatment ........................................................................................................ 12
3.2.3 Immunoblotting analyses of 3T3-L1 cells after Deltamethrin
treatment ........................................................................................................ 12
3.2.3.1 Statistical analyses ...................................................................... 14
4. RESULTS .................................................................................................................................. 15
4.1 Adipocyte accumulation after deltamethrin treatment ............................................... 15
4.2 Immunoblotting analyses ........................................................................................... 16
5. DISCUSSION ............................................................................................................................ 18

vi

APPENDICES
1. LIPID ACCUMULATION WITH BOSCALID TREATMENT ............................................. 21
2. LIPID ACCUMULATION WITH PARATHION TREATMENT .......................................... 22
3. LIPID ACCUMULATION WITH MALATHION TREATMENT ......................................... 23
BIBLIOGRAPHY .......................................................................................................................... 24

vii

CHAPTER 1
INTRODUCTION

Obesity is the primary factor to many diseases that threaten humans today.
According to a recent update by the World Health Organization, obesity in the world
today has more than doubled since 1980. In 2014, thirty-nine percent of all adults in the
world (more than 1.9 billion adults) were overweight and thirteen percent (over 600
million adults) were identified as obese. The statistics also reveal that in most countries,
being overweight and obese is more fatal than being underweight, due to the numerous
diseases that linked with overweight and obesity (WHO, 2015). As it is a growing global
concern, recent studies have examined many variables in their relation to obesity
(Spiegelman & Flier, 2001). One of the variables that come into play is environmental
contaminant, including insecticides. Insecticides are widely used in agriculture, applied
on crops to control and treat pests. Thus, it will be important to determine the connection
between obesity and its related pathologies and insecticides (Montgomery et al., 2008;
Park et al., 2012).
Existing literature has independently inquired into the subject matters of obesity
and insecticides, but few have examined the direct relationship between the two. The
purpose of this study is to contribute to the investigation of the connection between
obesity and insecticides, more specifically, the effect of deltamethrin on obesity
development. This thesis will focus on the relationship between lipid metabolism and
deltamethrin, an insecticide commonly used in pest control; discuss existing literature,
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with a focus on obesity, pyrethroids, followed by an elaborate discussion of past
experiments on deltamethrin and its effect on fat accumulation in 3T3-L1 cells.

2

CHAPTER 2
LITERATURE REVIEW

2.1

Obesity
Many studies have shown the escalation of obesity in the world today. In addition

to the statistics reported by WHO, there is an estimate that one third of the American
population today is obese. With alarming health consequences and disorders, obesity is
also increasing among children, foreseeing considerable health problems in the years to
come (Spiegelman & Flier, 2001). As we ponder about this epidemic, we must
understand all possible variables in obesity development. Since food is our only energy
intake, we must investigate the food that humans consume and determine its influence on
the energy balance. Considering that insecticides are used to treat the food most humans
eat, it is important to study insecticides and examine how our bodies are affected by this
diet (Park et al., 2012).
Obesity is defined as weight gain caused by the increase of adiposity. The
increase in body weight, specifically body fat mass, is a result of energy storage, a
disproportion between energy intake and expenditure, excess energy is stored as body fat
(Spiegelman & Flier, 2001). Fat storage and obesity are further defined by an imbalance
of the energy balance; the energy balance equation is as follows,

[Energy Intake] - [Energy Expenditure] = [Energy Stored] (Jéquier, 2002)
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Energy intake is defined by food consumption. Energy can be also spent as the
basal metabolism of the body in keeping its functions. Other energy expenditure is
characterized by physical activity as well as adaptive thermogenesis. Stored energy
occurs only if the energy intake is greater than energy expenditure (Spiegelman & Flier,
2001). An imbalance of the energy balance will lead to obesity, as energy is constantly
stored in the body as excess fat.
It is also known that regulation of body weight also influence by other factors,
such as environmental, psychosocial, and genetic factors. However, since humans have
not evolved for many centuries, research claims that the environment and lifestyle are the
primary causes of obesity. Food availability and composition today tend to lead to
overeating, which result in excess energy and therefore, an imbalance of the energy
balance. Additionally, the decrease in physical activity is also an essential contribution to
obesity, particularly since the lower energy expenditure lowers metabolism rates
(Spiegelman & Flier, 2001; Jéquier, 2002).

2.2

Development of synthetic pyrethroids
Pyrethroids are derivatives of pyrethrins, naturally occurring insecticide in

Chrysanthemum cinerarifolium flower. Synthetic pyrethroids were created to modify the
structure of natural pyrethrins to enhance photostability and lower mammalian toxicity.
Cyclopropane carboxylic acid moieties, or equivalent linked to aromatic alcohols through
a central ester bond, are found in most pyrethroids and is critical for their efficacy.
Pyrethroid insecticides have high insecticidal potency and are universally used in
agriculture as well as veterinary, medical, and household uses (Tayebati et al., 2009;
4

Nieradko-Iwanicka & Borzęcki, 2014). It is noted that in the last two decades, the use of
pyrethroids has been on the rise (Wolansky & Harrill, 2007). The use of pyrethroids
began in the 1970s; by the mid-90s in the world insecticide market, pyrethroids
represented 23% of the U.S. market (Soderlund et al., 2001; Rehman et al., 2006).
One example of this pyrethroid structure modification is when an α-cyano group
is added to the alcohol moiety, providing greater insecticidal activity, it also increased
about one order of magnitude in lethal potency on rodents. The variations in the identity
and position of halogenated and hydrophobic chemical groups resulted in approximately
three orders of magnitude of potency in the rat, from tefluthrin (with an oral LD50 of
22mg/kg) to etofenprox (with an oral LD50 of 10,000 mg/kg). Similarly, bifenthrin and
permethrin are very similar in structure and physical properties; with isomeric enrichment,
bifenthrin is the successive generation of permethrin, which represented improved
photostability as well as an increase in insecticidal activity and mammalian toxicity.
However, when comparing to permethrin, bifenthrin contains a 10- to 100-fold oral LD50
in rats (Wolansky & Harrill, 2007).
Pyrethroids are classified as type I and type II. The two subclasses are divided
according to their chemical structures as well as the intoxication syndrome of the T
(tremor) or CS (choreoathetosis with salivation). Cyano-group is only found in type II
pyrethroids at the carboxyl α position (α-carboxyl) (Verschoyle and Aldridge, 1980;
Soderlund et al., 2001). Type I pyrethroids leads to repetitive activity whereas type II
pyrethroids block nerve conduction, although both types causing paralysis and deaths
(Armstrong et al., 2012).
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Pyrethroids act on the nervous system and stimulate neurotoxicity (Crofton et al.,
1995; Wu & Liu, 1999). Pyrethroids cause disturbing kinetics of the voltage-sensitive
sodium channels, where the sodium permeability is briefly heightened in the nerve
membrane that controls the nerve action potential (Narahashi, 1986). In addition to
voltage-sensitive sodium, pyrethroids target calcium and chloride channels in both insects
and mammals; mammals are three magnitudes less sensitive to pyrethroids than insects,
primarily due to presence of multiple sodium channel isoforms, faster metabolism, higher
body temperature, and lower sensitivity to analogous ion channel target sites (Ray & Fry,
2006; Soderlund et al., 2001; Armstrong et al., 2012). Typically, pyrethroids act primarily
on neurons and muscles, the excitable cells, shown various responses, such as moderate
doses increase motor activity, higher doses cause immobility, and the highest doses lead
to immediate hind-limb paralysis, movement incoordination, prostration, and death
(Nieradko-Iwanicka & Borzęcki, 2014). In addition, recent studies reported genotoxicity,
immunotoxicity, tumorigenicity, gastrointestinal system, allergic reactions, toxicity to
cardiovascular and respiratory systems, such as respiratory failure (Soderlund et al., 2001;
Rehman et al., 2006; Tayebati et al., 2009).
Prevalent use of pyrethroids increases human exposure to this poison; pyrethroid
residues have been found in agricultural sediments, residential grounds, childcare centers,
and the human urine (Harrill et al., 2008). Humans, though non-target organisms, are
exposed to the highest doses of pyrethroids during crop application (Nieradko-Iwanicka
& Borzęcki, 2014).

6

2.3

Deltamethrin
Among the various types of pyrethroid insecticides, deltamethrin (type II) was

identified as having minimal toxicity with rapid biodegradability in animals (Sharma et
al., 2013). Thus, it was widely used as household insecticide products, fighting malaria as
well as other vector-borne diseases (Sharma et al., 2013). However, recent studies reveal
that deltamethrin can be toxic to both mammals and non-mammals (Rehman et al., 2005).
Deltamethrin has been reported to induce oxidative stress as shown in the
increased lipid peroxidation after exposure to deltamethrin, which is mainly metabolized
in the liver (Rehman et al., 2005; Armstrong et al., 2012). It is indicated that primary
toxic signs in animals include excessive salivation, decrease in activity, labored breathing,
gasping, impaired limb function, autonomic nervous system dysfunction, tremors,
convulsions, and death (Frank & Kellner, 2000). Deltamethrin causes nerve cell loss,
nerve cell interference in the frontal cortex and the dentate gyrus, astrogliosis, also
known as astrocytosis, resulting in decreased motor activity, decreased operant response
rates, decreased acoustic startle amplitudes, loss of righting reflex, and impaired
performance on an inclined plane are reported in rats with acute exposure to deltamethrin
(Crofton et al., 1995; Tayebati et al., 2009). In addition, deltamethrin is known to cause
nephrotoxicity, reproductive toxicity, genotoxicity, and immunotoxicity (Sharma et al.,
2013; Shona et al., 2010; Rehman et al., 2005).
Toxicity of deltamethrin occurs through direct exposure in the form of vapor
and/or consumption via food and water. Studies show that deltamethrin is persistent in
the body fat of animals, including brain, with a half-life of 5-6 days (Galal et al., 2014;
Armstrong et al., 2012). Major metabolites of deltamethrin, such as cis-(2,27

dibromovinyl)-2,2-dimethylcyclopropane-1-carboxylic acid (Br2CA) and 3phenoxybenzoic acid (3-PBA), are found in the urine of people residing in rural areas
without job-related exposure to deltamethrin. Consequently, residues of deltamethrin
were found in breast milk (Sharma et al., 2013). Thus, this finding implies the widespread
deltamethrin exposure of the general public (Nieradko-Iwanicka and Borzęcki, 2014).

2.4

3T3-L1 Adipocytes
Adipocytes are the primary cells in fat tissue, which accumulate excess fat in the

form of triglyceride. The development of obesity is induced either or both by increased
adipocyte cell number and/or size, called adipogenesis (Park et al., 2011; Ling et al.,
2011). Adipogenesis includes the proliferation of fat cells that is followed by
differentiation led by changes of adipogenetic gene expression, morphology, and
hormone sensitivity.
3T3-L1 is a pre-adipocyte cell line cloned from 3T3, the mouse embryo
fibroblasts (Green & Meuth, 1974; Student et al., 1979). 3T3-L1 was first discovered by
clonal expansion from murine Swiss 3T3 cells. Differentiation of 3T3-L1 cells take place
in culture where it gathers the characteristics of adipocytes (Student et al., 1979). Once
they reach confluence, 3T3-L1 cells stop proliferation and stay stagnant for a period of
time and then differentiated into adipocyte-like cells, which can accumulate triglyceride
(Green & Meuth, 1974; Zebisch et al., 2012). Common differentiation agents used are
insulin, dexamethasone, and 3-isobuty1-1-methylxanthine (IBMX); 3T3-L1 cells are
treated at concentrations of the following sequence, 1 μg/ml, 0.25 μM, and 0.5 mM.
Approximately four days after the treatment, lipid accumulation occurs where lipid
8

droplets are collected, and over cultivation time, they begin to grow in both number and
size (Zebisch et al., 2012). Due to this particular characteristic, 3T3-L1 cells are
commonly used in in vitro experiments as model system of adipogenesis (Zebisch et al.,
2012).
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CHAPTER 3
MATERIALS and METHODS

3.1

Materials

3.1.1

Differentiation of 3T3-L1 cells, and quantification of triglyceride and protein
3T3-L1 cells were purchased from American Type Culture Collection (Manassas,

VA). Dulbecco’s modified Eagle’s medium (DMEM), fetal bovine serum (FBS), insulin,
dexamethasone, methylisobutylxanthin (IBMX) and trypsin were purchased from
Sigma−Aldrich Co. (St. Louis, MO). Penicillin Streptomycin Amphotericin B were
purchased from GE Healthcare (Logan, UT). Triglyceride and protein quantified kits (DC
protein assay kits) were bought from Genzyme Diagnostics (Charlottetown, PE, Canada)
and Bio-Rad Co. (Hercules, CA).

3.1.2

Adipocyte accumulation in 3T3-L1 cells after insecticide treatment

All 3T3-L1 cell culture materials were obtained in the same way as previously
mentioned (St. Louis, MO). Deltamethrin ([(S)-Cyano-(3-phenoxyphenyl)-methyl]
(1R,3R)-3-(2,2-dibromoethenyl)-2,2-dimethyl-cyclopropane-1-carboxylate and dimethyl
sulfoxide (DMSO) were purchased from Sigma−Aldrich Co. (St. Louis, MO).

3.1.3

Immunoblotting analyses of 3T3-L1 cells after deltamethrin treatment
Radioimmunoprecipitation assay buffer (RIPA buffer) with

ethylenediaminetetraacetic acid (EDTA) and ethylene glycol tetraacetic acid
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(EGTA) supplemented 1% protease inhibitor cocktail was purchased from Boston
Bioproducts Inc. (Ashland, MA). The protease inhibitor cocktail and phosphatase
inhibitors were purchased from Thermo Scientific (Rockford, IL). The DC protein assay
kit was purchased from Bio-Rad Co. (Hercules, CA). The Immobilon P membrane was
bought from Millipore (Bedford, MA). Albumin, Bovine Fraction V (BSA) was
purchased from RPI, Corp (Mount Prospect, IL). Primary antibodies peroxisomeproliferator activated receptor-γ (PPARγ) and glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) were purchased from Santa Cruz Biotechnology, Inc. (Santa
Cruz, CA). Primary rabbit antibodies for acetyl-CoA carboxylase (ACC), phosphorylated
ACC (pACC), AMP-activated protein kinase-α (AMPKα), phosphorylated AMPKα
(pAMPKα), and CCAAT/enhancer-binding protein α (C/EBPα) and horseradish
peroxidase conjugated goat anti-rabbit IgG (the secondary antibody) were purchased
from Cell Signaling (Beverly, MA). The Clarity™ Western ECL Substrate Kit was
purchased from Bio-Rad Co. (Hercules, CA). The Image Station 4000MM was purchased
from Carestream Health (New Haven, CT).

3.2

Methods

3.2.1

Differentiation of 3T3-L1 cells, and quantification of triglyceride and protein
3T3-L1 cells were cultured in DMEM that contained 10% FBS and 1% Penicillin

Streptomycin Amphotericin B at 37°C in a 5% CO2 incubator. After 48 hours postconfluence (marked Day 0), the medium was changed with a mixture of insulin (1
μg/mL), dexamethasone (1 μM), IBMX (0.5 mM) and DMEM that contained 10% FBS
and 10% Penicillin Streptomycin Amphotericin B. On Day 2, the medium was changed
11

with a mixture of insulin (1 μg/mL) and DMEM. On Day 4, the medium was replaced by
DMEM that contained 10% FBS and 10% Penicillin Streptomycin Amphotericin B only.
On Day 6, all the steps from Day 4 were repeated and the 3T3-L1 cells were harvested on
Day 8 to do the quantification of triglyceride and protein. In order to measure the
triglyceride and protein of 3T3-L1 cells, the medium was removed from the culture plate.
All plates were washed by PBS twice and harvested. The amount of triglyceride and
protein contents in the cell lysates were determined by the kits. The triglyceride content
was normalized by protein.

3.2.2

Lipid accumulation in 3T3-L1 adipocytes after Deltamethrin treatment
All preparations of 3T3-L1 cells were the same as mentioned above. Deltamethrin

was treated on 3T3-L1 cells at the final concentration of 1nM, 10nM, 100nM, 1μM,
10μM and control. Deltamethrin was prepared from deltamethrin analytical standard
(10mM) with added DMSO and kept at the temperature of -20°C. On Day 0, the medium
was changed with deltamethrin. The final concentration of DMSO was 0.02% in all
treatments including control. Cell viability was measured by a 3-(4,5-dimethylthiazolyl2)-2, 5-diphenyltetrazolium bromide (MTT); and the deltamethrin concentrations did not
affect the cell viability. Deltamethrin were refreshed every 2 days. On day 8, cells were
harvested to do the quantification of triglyceride and protein.

3.2.3

Immunoblotting analyses of 3T3-L1 cells after Deltamethrin treatment
All 3T3-L1 cells were washed twice with cold phosphate buffered saline
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(PBS) and 50-80μL RIPA buffer with protease inhibitor cocktail and phosphatase
inhibitor cocktail was added into each well to lyse all 3T3-L1 cells. All steps of the
procedure were handled on ice. Centrifuged at 12,000g for 15 min at 4 °C after 30
minutes. The protein quantification was determined by DC protein assay kit. About
~50μg (or ≤ 100μg) samples were separated by 8% or 10% SDS-polyacrylamide gel and
transferred to the Immobilin P membrane.
For blocking, the membranes were blocked with tris-buffered saline with Tween
20 (TBST). The blocking solution was made with 5% skim milk or bovine serum
albumin (BSA) in TBST. The membrane was then incubated for 60 minutes under
agitation at room temperature. Finally, it is rinsed four times for 5 minutes by TBST.
As for the incubation of antibody, the primary rabbit antibody is diluted in
blocking solution with 5% skim milk or BSA at the recommended dilution. The antibody
consists of phosphorylated acetyl-CoA carboxylase (1:1000 p-ACC), acetyl-CoA
carboxylase (1:1000 ACC), CCAAT/enhancer-binding protein α (1:1000 C/EBPα ),
peroxisome proliferator-activated receptor γ (PPARγ 1:1000), AMP-activated protein
kinase α (AMPKα, 1:1000) and phosphorylated AMP-activated protein kinase α
(pAMPKα, 1:1000). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH 1:3000) was
used as internal control while horseradish peroxidase mixed with goat anti-rabbit IgG
(1:5000) was used as secondary antibody. The membrane was incubated in the primary
antibody for 24 hours in a room at 4°C. Afterwards, the membrane was washed four
times for 5 minutes by TBST and incubated in secondary antibody for one hour. Then,
the membrane was again washed four times for 5 minutes with TBST. As for imaging
detection, ECL oxidizing and ECL enhancer were mixed at a 1:1 ratio. The membrane
13

was incubated with agitation for 5 minutes. Image Station 4000MM (Carestream Health,
New Haven, CT) was used for imaging detection.

3.2.3.1 Statistical analyses
The results of this experiment were analyzed using the analysis of variance
procedure (ANOVA) using the Statistical Analysis System (SAS Institute, Cary, NC).
Two-way ANOVA with treatment dose differences and time of experiment were
measured using Tukey’s multiple-range test. The significance of difference was defined
at P < 0.05.
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CHAPTER 4
RESULTS

4.1

Adipocyte accumulation after deltamethrin treatment
The figures below show the quantification of triglyceride and protein of 3T3-L1

cells treated by deltamethrin. As shown in Figure 1, the triglyceride content gradually
increases with the deltamethrin concentration. The lowest concentration of deltamethrin
with significant increase compared to the control is at 100nM.

Figure 1. Increased lipid accumulation is observed in differentiation of 3T3-L1 adipocytes with deltamethrin treatment.
During differentiation period, various concentrations of deltamethrin were used to treat cells for 8 days. Numbers are
mean ± SE (n = 8). Means with different letters indicate significant difference at P < 0.05.
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4.2

Immunoblotting analyses
The effects of deltamethrin on expression of target proteins in adipogenesis

are illustrated in the results in figure 2. In the present study, six different concentrations
were initially selected for deltamethrin treatment during adipocyte differentiation: control,
1nM, 10nM, 100nM, 1μM, and 10μM. As shown in Figure 1, there were no significant
differences between 1nM and 10nM after 8 days of treatment. Therefore, four
concentrations were chosen in immunoblotting analyses (Figure 2).
In most of the protein expressions, results at 100nM were comparable to that of
control, with no significant increase observed. However, the significant increases were
observed in the protein expressions at 10μM. There was a 35% increase with ACC, 31%
increase with C/EBPα, 26% increase with PPARγ, 26% increase with AMPKα and 24%
decrease with pACC/ACC ratio and pAMPKα/AMPKα ratio compared to respective
controls (Figure 2). pACC and pAMPKα were the only protein markers that were
unresponsive to deltamethrin treatment.

16

Figure 2. Effects of deltamethrin on target protein expressions in adipogenesis: pACC; ACC; pACC/ACC ratio;
C/EBPα; PPARγ; pAMPKα; AMPKα; pAMPKα/AMPKα ratio. Deltamethrin was used to treat the cells for 8 days.
GAPDH was used as an internal control. Numbers are mean ± S.E. (n=11 in pACC; ACC; pACC/ACC ratio and n= 12
in others, collected from 3 independent experiment). Means with different letters indicate significantly different at p<
0.05.
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CHAPTER 5
DISCUSSION

Ling et al. (2011) report that excessive preadipocyte differentiation leads to lipid
accumulation. In the present study, the exposure of deltamethrin stimulated adipogenesis
in 3T3-L1 adipocyte model. This observation was shown in the results of the experiments
of deltamethrin on target protein expressions, pACC, ACC, C/EBPα, PPARγ, pAMPKα,
and AMPKα, suggesting that deltamethrin exposure contributes to adipogenesis.
Previous studies have investigated the effect of other insecticides, including
another pyrethroid, on adipogenesis. Kim et al. (2013) used the same 3T3-L1 adipocyte
model and reported that permethrin at 10μM and 20 μM resulted in significant increase in
triglyceride deposition after 6 day treatment. In a different study, Kim et al. (2015) also
observed that dichlorodiphenyltrichloroethane (DDT) and
dichlorodiphenyldichloroethylene (DDE) increased lipid accumulation and trigger
adipogenesis. The results of the current study are consistent with these previous
publications. As with the study by Kim et al. (2013), significant increases in triglyceride
content were observed in at 10μM, this study also shows an increase in adipogenesis after
deltamethrin at 10μM.
When preadipocytes differentiate into adipocytes, transcription factors such as
C/EBPα family and PPARγ are necessary and are the crucial markers of adipogenesis
(Armstrong et al., 2012; Christy et al., 1989; Park et al., 2012). According to Kim et al.
(2015), DDT and DDE were observed with a dramatic increase in the protein expression
of C/EBPα and PPARγ. In this study, significantly increased protein expression of
18

C/EBPα and PPARγ were also observed after deltamethrin treatment, especially at 10μM.
These findings suggest that deltamethrin treatment stimulated preadipocyte
differentiation in the 3T3-L1 adipocyte model.
Daval et al. (2006) reported that the activation of AMPK inhibits preadipocyte
differentiation, and that treatment inhibits adipocyte differentiation as well as
transcription factors C/EBPα and PPARγ. Daval et al. (2006) defines ACC as the primary
enzyme of the lipogenic pathway and is a target protein of AMPK; ACC activity is
inhibited by phosphorylation. According to the findings of the present study, ACC and
AMPKα were affected by deltamethrin treatment, evident increases of nonphosphorylated forms and ratio of ACC and AMPKα after deltamethrin treatment are
observed in comparison with the control group. These results suggest that an increase in
active form of ACC results in an increase in fat synthesis, or lipogenesis. Therefore, since
deltamethrin treatment stimulates ACC, it is implied that deltamethrin promotes
adipogenesis.
It is important to note that while the results of this study suggest that deltamethrin
triggers lipid accumulation, weight gain is not a definite factor in the study. In one study,
Salem et al. (1988) experimented with adult male rabbits, and observed that the effect on
deltamethrin treatment on body weight decline. A different study, also using rat, found no
significant change on body weight after deltamethrin treatment (Tayebati et al., 2009).
Another study on mice, indicated a decline on food intake and weight gain as effects of
deltamethrin. Deltamethrin was administered at a concentration of 0 to 30 mg/kg bw per
day for a period of 10 days, and then 0 to 60 mg/kg bw per day for another 17 days
(McGregor, 2000). Moreover, findings indicate that mice exposed to deltamethrin gained
19

weight slower than those of the control group that were not exposed to deltamethrin
(Nieradko-Iwanicka, B. & Borzęcki, A., 2014). Without data of deltamethrin serum
concentrations from these animal studies, direct comparison of doses of deltamethrin
used in the current study and animal studies may not be possible. However, it was
previously reported that DDE (an organochlorine insecticide) has been detected at levels
as high as 2,542 ng/g lipids in serum, which is equivalent to ~7.3 M (Glynn et al., 2003).
Moreover, the serum levels of total fipronil (a phenylpyrazole insecticide) in orally
exposed patients were ranged from 0.12 to 9.15 μM (Mohamed et al., 2004) and it was
reported that fipronil and its metabolites bioaccumulate in adipose tissue (~70 μM)
(Dobozy, 2000). Based on these reports and high lipophilic characteristic of deltamethrin,
it is likely that deltamethrin and its metabolites remain and bioaccumulate in adipose
tissue that may reach concentrations we have tested in the current study. However, the
relevance of current study still needs to be confirmed in in vivo study.
In conclusion, the present study observed that deltamethrin treatment stimulates
adipogenesis in ACC, C/EBPα, PPARγ, and AMPKα. Since 3T3-L1 adipocyte cells were
selected as target treatment model in this study, it is possible that an in vivo study may
yield more precise results regarding effects of deltamethrin exposure. The limitations in
this study have led to partial findings in the connection between deltamethrin and obesity.
Thus, more in vivo studies of deltamethrin is necessary further understand the connection
between deltamethrin exposure and obesity. The studies will also inform the effects of
deltamethrin on non-target organisms.
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APPENDIX 1
LIPID ACCUMULATION WITH BOSCALID TREATMENT

Figure 3. Lipid accumulation is observed in differentiation of 3T3-L1 adipocytes with Boscalid treatment. During
differentiation period, various concentrations of Boscalid were used to treat cells for 8 days. Numbers are mean ± SE (n
= 8). Means with different letters indicate significant difference at P < 0.05.
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APPENDIX 2
LIPID ACCUMULATION WITH PARATHION TREATMENT

Figure 4. Lipid accumulation is observed in differentiation of 3T3-L1 adipocytes with Parathion treatment. During
differentiation period, various concentrations of Parathion were used to treat cells for 8 days. Numbers are mean ± SE
(n = 8). Means with different letters indicate significant difference at P < 0.05.
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APPENDIX 3
LIPID ACCUMULATION WITH MALATHION TREATMENT

Figure 5. Lipid accumulation is observed in differentiation of 3T3-L1 adipocytes with Malathion treatment. During
differentiation period, various concentrations of Malathion were used to treat cells for 8 days. Numbers are mean ± SE
(n = 8). Means with different letters indicate significant difference at P < 0.05.
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